These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35118438)

  • 1. Analysis of Delayed Vaccination Regimens: A Mathematical Modeling Approach.
    Gonzalez-Parra G
    Epidemiologia (Basel); 2021 Sep; 2(3):271-293. PubMed ID: 35118438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should We Delay the Second COVID-19 Vaccine Dose in Order to Optimize Rollout? A Mathematical Perspective.
    Berkane S; Harizi I; Tayebi A; Silverman MS; Stranges S
    Int J Public Health; 2021; 66():1604312. PubMed ID: 35140580
    [No Abstract]   [Full Text] [Related]  

  • 3. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Key Factors of a SARS-CoV-2 Vaccination Program: A Mathematical Modeling Approach.
    Martínez-Rodríguez D; Gonzalez-Parra G; Villanueva RJ
    Epidemiologia (Basel); 2021 Jun; 2(2):140-161. PubMed ID: 35141702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of optimal vaccination strategies for early COVID-19 pandemic using an age-structured mathematical model: A case study of the USA.
    Luebben G; González-Parra G; Cervantes B
    Math Biosci Eng; 2023 Apr; 20(6):10828-10865. PubMed ID: 37322963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and Public Trust: Containing COVID-19 in Cuba.
    Gorry C
    MEDICC Rev; 2022 Jan; 24(1):9-13. PubMed ID: 35157633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.
    Havumaki J; Meza R; Phares CR; Date K; Eisenberg MC
    BMC Infect Dis; 2019 Dec; 19(1):1075. PubMed ID: 31864298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the impact of delaying vaccination against SARS-CoV-2 assuming unlimited vaccine supply.
    Amaku M; Covas DT; Coutinho FAB; Azevedo RS; Massad E
    Theor Biol Med Model; 2021 Jul; 18(1):14. PubMed ID: 34325717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
    Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
    J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decisive conditions for strategic vaccination against SARS-CoV-2.
    Böttcher L; Nagler J
    Chaos; 2021 Oct; 31(10):101105. PubMed ID: 34717322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonality, mass vaccination and critical policy evaluation on global exit strategy of COVID-19 crisis.
    Roy I; Chapungu L; Nyambiya I
    Phys Chem Earth (2002); 2023 Jun; 130():103388. PubMed ID: 36923070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the anti-COVID-19 vaccination campaign in the Metropolitan Area of Milan (Lombardy Region, Northern Italy).
    Russo AG; Tunesi S; Consolazio D; Decarli A; Bergamaschi W
    Epidemiol Prev; 2021; 45(6):568-579. PubMed ID: 34791867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.